An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

NCT00474383 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Neoplasms

Interventions

DRUG: Abiraterone acetate
DRUG: Glucocorticoid

Sponsor

Cougar Biotechnology, Inc.